Organ on Chip Market By Product (Lungs on Chip, Heart on Chip, Liver in Chip, Kidney on Chip, Others), By End User (Research Institutes, Pharmaceutical Manufacturers) - Growth, Future Prospects and Competitive Analysis, 2018 – 2026

Enhancing the viability of preclinical expectations human drugs reactions is critical to reducing expensive failures in clinical trials. The pharmaceutical industry is confronting phenomenal challenges attributable to increasing expenses and the declining efficiency of drug research and development. Late advances in microfabrication, cell biology and microfluidics has empowered the improvement of micro-engineered models of the useful parts of human body known as the organ on chip. 

Organs on chip are micro-engineered biometric systems that imitate the main purpose of living organs. These micro-devices give a more precise model than traditional cell culture for recreating composite cell-matrix and cell-cell collaborations. In this manner, they possibly represent a fascinating tool for chemical and pharmaceutical applications. They additionally permit to contemplate human physiology for a particular organ and in this way empower the improvement of a novel in vitro disease models. Several research activities have been conducted by the different companies and research institutes to bring this advanced technology to the market. Currently, there are limited companies involved in the development of organ on chip, but it is expected that the number of players will increase in the future. 

The purpose of this research study titled ‘Organ on Chip Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026’ is to offer stakeholders, manufactures, business representatives and industry sponsors with exhaustive exploration to allow them to take planned initiatives and resolutions allied to the expectations in the global organ on chip market. This report presents and assesses the chief scenarios in the overall organ on chip market and the market size and forecast. 

This report classifies the worldwide organ on chip market in terms of products, end users, and geographical distribution. Based on product types, the global organ on chip market is classified into lungs on chip, heart on chip, liver on chip, kidney on chip, and others. The end users considered for the purpose of this study are research institutes and pharmaceutical manufacturers. Market size and forecast for every cited division for the period from 2016 to 2026 are offered in the report alongside particular CAGRs for the forecast period from 2018 to 2026. 

This report includes regional market divisions accompanied by leading countries, which are presented as follows:

  • Europe
    • Germany
    • United Kingdom
    • Rest of Europe
  • North America
    • Canada       
    • United States
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

This study covers a thorough depiction of the above-indicated market segments for the duration from 2016 to 2026. 

An exhaustive investigation of market situations has been provided in the report to get a proper comprehension of the market and the associated trends. Various tools are utilized in the report to decide the competition between foremost market players. The study additionally contains company profiling of the market players having a prominent hold on the overall organ on chip market market. Some of the foremost players in the global organ on chip market recorded in this study are: Ascendance Biotechnology, CN Bio Innovations, Emulate, Inc          ., HµREL Corporation, Insphero AG, MIMETAS B.V., Nortis Inc., TARA Biosystems, Inc., and TissUse GmbH.

For the purpose of this study, global organ on chip market is studied for their application in following usage areas:

  • Research Institutes
  • Pharmaceutical Manufacturers

Organ on Chip Market 

Among the considered usage areas, organ on chip technology enjoys the largest application in research institutes followed by pharmaceutical manufacturers. Higher affordability of research institutes for uptake of organ on chip, greater handling skills and new drug discovery are the foremost factors driving the organ on chip market in research institutes. It is further anticipated that the growing preference for early drug testing results and the need of more reliable data will enhance the demand for organ on chip during the forecast period. Therefore it is predictable that the growth of research institutes sector will be greater than the global benchmark during the forecast period.

Geographically, the global organ on chip market is composed of Latin America, Middle East & Africa, Europe, Asia Pacific, and North America.

Organ on Chip Market 

North America holds the major share in global organ on chip market trailed by Europe. Major reasons for the incumbent status of these regions are them being early adopters of new advanced technologies, presence a huge consumer base, and higher organ transplant rate. Furthermore, Asia Pacific is a remunerative market for the companies involved in organ on chip market. Though, widespread commercialization of this technology is not expected to happen in early years, as the market is still in initial stage in developed regions, it would take a couple of years before organizations can assume return on benefit. China and Japan are main market in the region. Need for advanced testing and research technologies and time saving techniques will enhance the market growth in the future. In the course of forecast duration 2018 to 2026, Europe is observed as the fastest growing region followed by Asia Pacific.

The geographical classification of the global organ on chip market is as follows:

  • Asia Pacific (Japan, China, and Rest of Asia Pacific)
  • North America (Canada & United States)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
  • Europe (Germany, U.K., and Rest of Europe)
  • Latin America (Mexico, Brazil, and Rest of Latin America)
Choose License Type
Trusted By
Related Report

Published Date:  Jan 2018
Category:  Medical Devices
Report ID:   58964
Report Format:   PDF
Pages:   120
Rating:    4.3 (21)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support